Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trialWilliam H. Marks, Denis Glotz, Nizam Mamode et al.|American Journal of Transplantation|2019Cited by 146